Abstract
Head and neck cancer (HNC) is one of the tumor types with the highest incidence in the world, consisting of a heterogeneous group of malignant neoplasms, which include tumors of the oral cavity, pharynx, larynx, and paranasal sinuses. Despite the treatments used, the prognosis is poor, with a survival of approximately 5 years for approximately 90% of patients. A protein commonly expressed…